SF Healthcare Week: Biohaven CEO Vlad Coric talks degraders, ion channel programs, and ADCs
He describes updates given for the degrader programs targeting IgG, IgA nephropathy, and peripartum cardiomyopathy.. Plus, ion channel programs BHV-7000 and BHV-2100, and ADCs including TROP2.
